Investigation of drug-porous adsorbent interactions in drug mixtures with selected porous adsorbents

Journal of Pharmaceutical Sciences

Volumn 96, Issue 4, 2007, Pages 851-863

  Madieh, Shadi ^a,b   Simone, Michael ^c   Wilson, Wendy ^c   Mehra, Dev ^c   Augsburger, Larry ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b GLAXOSMITHKLINE   (United States)

^c JM Huber Corp   (United States)

Author keywords

Adsorption; Amorphous; Dissolution; Excipients; Moisture sorption

Indexed keywords

CALCIUM SILICATE; DIPYRIDAMOLE; IBUPROFEN; PARACETAMOL; SILICA GEL; UNCLASSIFIED DRUG; ZEOPHARM;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ADSORPTION; DRUG MIXTURE; INFRARED SPECTROSCOPY; IONIZATION; POROSITY; X RAY DIFFRACTION;

EID: 34247529516     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20807     Document Type: Article

References (33)

1. Monkhouse DC, Lach JL. 1972. Use of adsorbents in enhancement of drug dissolution I. J Pharm Sci 61:1430-1435.
2. Monkhouse DC, Lach JL. 1972. Use of adsorbents in enhancement of drug dissolution II. J Pharm Sci 61:1435-1441.
3. Johansen H, Moller N. 1978. Solvent deposition method for enhancement of dissolution rate: Importance of drug-to-excipient ratio. J Pharm Sci 67:134-136.
4. Yang KY, Glemza R, Jarowski CI. 1979. Effects of amorphous silicon dioxides on drug dissolution. J Pharm Sci 68:560-565.
5. McGinity JW, Harris MR. 1980. Increasing dissolution rates of poorly water soluble drugs by adsorption to montmorillonite. Drug Dev Ind Pharm 6:35-48.
6. Konno T, Kinuno K. 1989. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. II. Application of reduced pressure treatment for the improvement of dissolution of flufenamic acid. Chem Pharm Bull (Tokyo) 37:2481-2484.
7. Hanawa T, Ikoma R, Watanabe A, Hidaka M, Sugihara M. 1996. Preparation and characterization of sealed heated mixture of ethenzamide and porous calcium silicate. Chem Pharm Bull 44: 1367-1371.
8. Alsaidan SM, Alsughayer AA, Eshra AG. 1998. Improved dissolution rate of indomethacin by adsorbents. Drug Dev Ind Pharm 24:389-394.
9. Kinoshita M, Baba K, Nagayasu A, Yamabe K, Shimooka T, Takeichi Y, Azuma M, Houchi H, Minakuchi K. 2002. Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate. J Pharm Sci 91:362-370.
10. Smirnova I, Suttiruengwong S, Seiler M, Arlt W. 2004. Dissolution rate enhancement by adsorption of poorly soluble drugs on hydrophilic silica aerogels. Pharm Dev Technol 9:443-452.
11. Pinnamaneni S, Das NG, Das SK. 2002. Formulation approaches for orally administered poorly soluble drugs. Pharmazie 57:291-300.
12. Liao CC, Jarowski CI. 1984. Dissolution rates of corticoid solutions dispersed on silicas. J Pharm Sci 73:401-403.
13. Hanawa T, Ikoma R, Sugihara M. 1997. Preparation and characterization of sealed heated mixture of sublimable compound and porous calcium silicate. Part 2. Investigation of the interaction between maltol and porous calcium silicate surface. Int J Pharm 154:1-8.
14. Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47-60.
15. Watanabe T, Wakiyama N, Usui F, Ikeda M, Isobe T, Senna M. 2001. Stability of amorphous indomethacin compounded with silica. Int J Pharm 226:81-91.
16. FDA. 1995. Guidance for industry, immediate release solid oral dosage forms-scale up and post-approval changes: Chemistry, manufacturing and controls, in vitro bioequivalence documentation. CDER_FDA: Rockville, MD (http://www.fda.gov/cder/guidance/cmc5.pdf; https://umail.umaryland. edu/exchweb/bin/redir.asp?URL=http://www.fda. gov/cder/guidance/cmc5.pdf).
17. Daniels R, Kerstiens B, Tischinger-Wagner H, Rupprecht H. 1986. Stability of drug adsorbates on silica. Drug Dev Ind Pharm 12:2127-2156.
18. I-Ssuer C, Macial GE. 1996. Probing hydrogen bonding and the local environment of silanols on silica surfaces via nuclear spin cross polarization dynamics. J A Chem Soc 118:401-406.
19. I-Ssuer C, Macial GE. 1997. A detailed model of local structure and silanol hydrogen bonding of silica gel surfaces. J Phys Chem 101:3052-3064.
20. Gupta MK, Tseng YC, Goldman D, Bogner RH. 2002. Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules. Pharm Res 19:1663-1672.
21. Ali AS, Yamamoto K, El-Sayed AM, Habib FS, Nakai Y. 1992. Molecular interaction between benzoic acid and florite and complex formation. Chem Pharm Bull 40:467-471.
22. Konno T, Kinuno K, Kataoka K. 1986. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. I. Effect of vapor pressure of the medicinals on changes in crystalline properties. Chem Pharm Bull (Tokyo) 34:301-307.
23. Yuasa H, Asahi D, Takashima Y, Kanaya Y, Shinozawa K. 1994. Application of calcium silicate for medicinal preparation. I. Solid preparation adsorbing an oily medicine to calcium silicate. Chem Pharm Bull (Tokyo) 42:2327-2331.
24. Pan X. 2002. The application of porous adsorbents to increase the dissolution rate of low solubility drugs, dissertation. University of Maryland.
25. McGinity JW, Lach JL. 1976. In vitro adsorption of various pharmaceuticals to montmorillonite. J Pharm Sci 65:896-902.
26. Shaw LR, Irwin WJ, Grattan TJ, Conway BR. 2005. The effect of selected water-soluble excipients on the dissolution of paracetamol and Ibuprofen. Drug Dev Ind Pharm 31:515-525.
27. Healy AM, Corrigan OI. 1992. Predicting the dissolution rate of ibuprofen-acidic excipient compressed mixtures in reactive media. J Pharm Sci 84:167-173.
28. Leeson LJ, Mattocks AM. 1958. Decomposition of aspirin in the solid state. J Am Pharm Assoc Am Pharm Assoc (Baltim) 47:329-333.
29. Glombitza BW, Oelkrug D, Schmidt PC. 1994. Surface acidity of solid pharmaceutical excipients I. Determination of the surface acidity. Eur J Pharm Biopharm 40:289-293.
30. Glombitza BW, Schmidt PC. 1995. Surface acidity of solid pharmaceutical excipients II. Effect of the surface acidity on the decomposition rate of acetylsalicylic acid. Euro J Pharm Biopharm 41: 114-119.
31. Scheef CA, Oelkrug D, Schmidt PC. 1998. Surface acidity of solid pharmaceutical excipients III. Excipients for solid dosage forms. Eur J Pharm Biopharm 46:209-213.
32. Scheef CA, Schmidt PC. 1998. Influence of surface acidity of excipients on the solid state stability of pirenzepine. STP Pharma Sci 8:91-97.
33. Zhou R, Moench P, Heran C, Lu X, Mathias N, Faria TN, Wall DA, Hussain MA, Smith RL, Sun D. 2005. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: Development of a canine model. Pharm Res 22:188-192.